Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions
NCT04509687 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-08-12
Summary
In China, there is a serious shortage of pathologists who can perform on-site cytological diagnosis. As a result, there are few centers that can conduct ROSE in China, which limits the diagnostic accuracy of EUS-FNA to a certain extent. Previous research reports on whether endoscopists could be trained for ROSE were controversial, which may be related to the lack of standardization of the training of endoscopists. There is no training program for training endoscopists to systematically process pathological specimens, operate microscopes, read the adequacy of cytological specimens, and evaluate the atypia of cytological specimens in China. Therefore, our center intends to carry out a training for endoscopists to compare the improvement of endoscopists' ROSE operating ability before and after the training, and to evaluate the practice of each endoscopist to perform on-site rapid cytology specimens of solid pancreatic lesions.
Conditions
Sponsors & Collaborators
-
Changhai Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2020-09-30
- Completion
- 2020-11-01
Countries
- China
Study Locations
More Related Trials
-
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
NCT05476978 ·Status: COMPLETED
-
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue
NCT03140592 ·Status: UNKNOWN
-
Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer
NCT02190071 ·Status: COMPLETED
-
Effects of Different Methods of PDAC Specimen Acquisition on Primary Cell Culture and Application
NCT04797676 ·Status: UNKNOWN
-
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer
NCT06108531 ·Status: ENROLLING_BY_INVITATION
-
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer
NCT04293497 ·Status: COMPLETED ·Phase: NA
-
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery
NCT01646697 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer
NCT05043532 ·Status: UNKNOWN ·Phase: NA
-
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer
NCT04636788 ·Status: UNKNOWN ·Phase: NA
-
Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
NCT05907824 ·Status: UNKNOWN
-
Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer
NCT05729737 ·Status: RECRUITING
-
The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
NCT03076502 ·Status: UNKNOWN
-
Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer
NCT05187416 ·Status: UNKNOWN
-
Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results
NCT05226572 ·Status: COMPLETED
-
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
NCT05047991 ·Status: UNKNOWN ·Phase: PHASE2
-
AI Assisted the Diagnosis of Pancreatic Solid Lesions
NCT05706415 ·Status: UNKNOWN
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Peri-operative SLOG for Localized Pancreatic Cancer
NCT05048524 ·Status: RECRUITING ·Phase: PHASE2
-
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
NCT02716207 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle
NCT02678442 ·Status: COMPLETED ·Phase: NA
-
In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer
NCT05842187 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)
NCT06278454 ·Status: RECRUITING ·Phase: PHASE1
-
Microbiome Characterization in Fatty Pancreas
NCT06938646 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of a Novel 22-gauge Core Biopsy Needle
NCT01598194 ·Status: COMPLETED ·Phase: NA
-
Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses
NCT02911974 ·Status: COMPLETED ·Phase: NA